Literature DB >> 2457442

Developmental and pathophysiological aspects of the myelin-associated glycoprotein.

R O Brady1, R H Quarles.   

Abstract

1. A glycoslylated sulfate-containing protein known as myelin-associated glycoprotein (MAG) appears to be unique to the central and peripheral nervous systems. This component has been characterized and cDNA clones have been isolated. 2. MAG is a member of the immunoglobulin superfamily. The principal form of MAG synthesized in brain during active myelination has an apparent molecular weight of 100,000. Alternate exon splicing leads to an additional 5000-dalton smaller form with a different C terminus. 3. In patients with multiple sclerosis, MAG is rapidly lost in areas of active disease. It is immunologically reactive in patients with benign monoclonal gammopathy associated with peripheral neuropathy. 4. The role of MAG in the formation of the myelin sheath and its participation in autoimmune neurological disorders are outlined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457442     DOI: 10.1007/bf00711240

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  50 in total

1.  Jimpy mice: quantitation of myelin-associated glycoprotein and other proteins.

Authors:  K Yanagisawa; R H Quarles
Journal:  J Neurochem       Date:  1986-07       Impact factor: 5.372

2.  Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis.

Authors:  J R Möller; K Yanagisawa; R O Brady; W W Tourtellotte; R H Quarles
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

3.  Anomalies of myelin-associated glycoproteins in 'Quaking' mice.

Authors:  J M Matthieu; R O Brady; R H Quarles
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

4.  Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy.

Authors:  D K Chou; A A Ilyas; J E Evans; C Costello; R H Quarles; F B Jungalwala
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

5.  Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat.

Authors:  N H Sternberger; R H Quarles; Y Itoyama; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 6.  CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.

Authors:  A Wajgt; M Górny
Journal:  Acta Neurol Scand       Date:  1983-11       Impact factor: 3.209

7.  Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1.

Authors:  R C McGarry; S L Helfand; R H Quarles; J C Roder
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

8.  Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy.

Authors:  P E Braun; D E Frail; N Latov
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

9.  Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing.

Authors:  C Lai; M A Brow; K A Nave; A B Noronha; R H Quarles; F E Bloom; R J Milner; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Immunocytochemical studies of quaking mice support a role for the myelin-associated glycoprotein in forming and maintaining the periaxonal space and periaxonal cytoplasmic collar of myelinating Schwann cells.

Authors:  B D Trapp; R H Quarles; K Suzuki
Journal:  J Cell Biol       Date:  1984-08       Impact factor: 10.539

View more
  1 in total

1.  Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

Authors:  N Kerlero de Rosbo; R Milo; M B Lees; D Burger; C C Bernard; A Ben-Nun
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.